biomedicina slovenica


pr=Čufer : 182-281

  1. von Minckwitz Gunter; Schwedler Kathrin; Schmidt Marcus; Čufer Tanja
    Trastuzumab beyond progression: overall survival analysis of the GBG 26/BIG 3-05 phase III study in HER2-positive breast cancer
    2011
  2. Bonnefoi Herve; Piccart Martine; Bogaerts Jan; Čufer Tanja
    TP53 status for prediction of sensitivity to taxane versus non-taxane neoadjuvant chemotherapy in breast cancer (EORTC 10994/BIG 1-00): a randomised phase 3 trial
    2011
  3. Slamon Denis; Eiermann Wolfgang; Robert Nicholas; Pienkowski Tadeusz; Martin Miguel; Press Michael; Mackey John; Matos Erika; Čufer Tanja; Takač Iztok
    Adjuvant trastuzumab in HER2-positive breast cancer
    2011
  4. Regan MM; Price KN; Giobbie-Hurder A; Thuerliman B; Gelber RD; Čufer T; Pajk B; Červek J
    Interpreting Breast International Group (BIG) 1-98: a randomized, double-blind, phase III trial comparing letrozole and tamoxifen as adjuvant endocrine therapy for postmenopausal women with hormone receptor-positive, early breast cancer
    2011
  5. Darby S; McGale P; Correa C; Čufer T
    Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials
    2011
  6. Trobec Katja; Knez Lea; Meško-Brguljan Pika; Čufer Tanja; Lainščak Mitja
    Estimation of renal function in lung cancer patients
    2012
  7. Serša Gregor; Čufer Tanja; Paulin-Košir Marija Snežna; Čemažar Maja; Snoj Marko
    Electrochemotherapy of chest wall breast cancer recurrence
    2011
  8. Buturović-Ponikvar J; Adamlje T; Blanuša D; Ceglar Z; Cimerman-Steklasa S; Čufer A; Drozg A; Ekart R; Guček A; Kandus A; Kapun S; Kralj-Lopert S; Kralj S; Malovrh M; Močivnik M; Novljan G; Ponikvar R; Rus I; Saksida S; Stavanovic Z; Vujkovic B
    Vascular access for hemodialysis patients in Slovenia - data from the Slovenian renal replacement therapy registry
    2011
  9. Mlakar Jernej; Čufer Tanja; Triller Nadja; Sadikov Aleksander; Šumer Tijana Taja
    Safety and efficiency of treatment of advanced NSCLC with non-squamous histology with pemetrexed and platinum derivate combination in routine clinical practice; experience at University Clinic Golnik
    2011
  10. Turnšek Nina; Mohorčič Katja; Sadikov Aleksander; Čufer Tanja
    Neutropenia in lung cancer patients treated with chemotherapy in a routine clinical practice - an institutional experience
    2011
  11. Kern Izidor; Kovačević Mile; Sodja Eva; Čufer Tanja
    Topoisomerase 2alpha in small cell lung carcinoma
    2011
  12. Triller Nadja; Debeljak Andrej; Čufer Tanja
    Pljučni rak in Golnik: včeraj, danes, jutri
    2011
  13. Šumer Tijana Taja; Čufer Tanja
    Changing to another TKI in treatment to metastatic NSCLC
    2011
  14. Knez Lea; Ovčariček Tanja; Sadikov Aleksander; Sodja Eva; Kern Izidor; Košnik Mitja; Čufer Tanja
    MDR1 polymorphisms G2677T/A and C3435T are independent predictive markers in small-cell lung cancer patients treated with chemotherapy
    2011
  15. Sodja Eva; Knez Lea; Ovčariček Tanja; Kern Izidor; Košnik Mitja; Sadikov Aleksander; Čufer Tanja
    Clinical impact of ERCC1 protein expression in small-cell lung cancer patients treated with platinum-based chemotherapy
    2011
  16. Unk Mojca; Kern Izidor; Čufer Tanja
    Primitive neuro-ectodermal tumour of the lung - a case report
    2011
  17. Lešničar Hotimir; Čufer Tanja; Serša Gregor; Sadikov Aleksander
    Splošna načela klinične onkologije
    2009
  18. Žgajnar Janez; Bilban-Jakopin Cvetka; Čufer Tanja
    Rak dojk
    2009
  19. Kern I; Kovačevič M; Čufer T
    Topoisomerase IIalpha expression and gene amplification in small cell lung carcinoma
    2011
  20. Čufer Tanja
    Adjuvant chemotherapy for early breast cancer
    2011
  21. Čufer Tanja; Južnič Šetina Tanja; Šeruga Boštjan; Turnšek Nina; Gregorič Brigita; Matičič Mojca
    Presejanje na okužbo z virusom hepatitisa B in preprečevanje reaktivacije hepatitisa B
    2011
  22. Buturović-Ponikvar Jadranka; Gubenšek Jakob; Arnol Miha; Adamlje Tone; Blanusa Danica; Ceglar Zlata; Cimerman-Steklasa Sonja; Čufer Andrej; Drozg Andrej; Ekart Robert; Guček Andrej; Kandus Aljoša; Kapun Sonja; Kralj-Lopert Simona; Kralj Stojan; Malovrh Marko; Močivnik Marjan; Novljan Gregor; Ponikvar Rafael; Rukavina Nikola; Rus Igor; Saksida Silvana; Stevanović Živojin; Vujkovac Bojan
    Slovenian renal replacement therapy registry: excerpts from the 2008 annual report
    2011
  23. Humar Mojca; Čufer Tanja
    Secondary breast angiosarcoma: a case report
    2011
  24. Knez L; Ovčariček T; Sadikov A; Sodja E; Kern I; Košnik M; Čufer T
    MDR1 polymorphisms G2677T/A and C3435T are independent predictive markers in small-cell lung cancer patients treated with chemotherapy
    2011
  25. Šumer Tijana Taja; Čufer Tanja
    Changing to another TKI in treatment of metastatic NSCLC
    2011
  26. Sodja Eva; Knez Lea; Ovčariček Tanja; Kern Izidor; Košnik Mitja; Sadikov Aleksander; Čufer Tanja
    Clinical impact of ERCC1 protein expression in small-cell lung cancer patients treated with platinum-based chemotherapy
    2011
  27. Turnšek Nina; Dolžan Vita; Čufer Tanja
    Case report on adverse events of Erlotinib and Geftinib in advanced NSCLC patient: CYP3A4 and CYP2D6 polymorphism
    2011
  28. Ovčariček T; Knez L; Sadikov A; Čufer T
    C-reactive protein: can it predict response and progression free survival in small-cell lung cancer patients treated with chemotherapy
    2011
  29. Ovčariček T; Sadikov A; Sodja E; Kern I; Čufer T
    Treatment of advanced non-small cell lung cancer (NSCLS) with tyrosine kinase inhibitors (TKI): epidermal growth factor receptor (EGFR) mutational status and its implications
    2011
  30. Unk Mojca; Kern Izidor; Čufer Tanja
    Primitive neuro-ectodermal tumour of the lung - a case report
    2011
  31. Knez Lea; Sodja Eva; Kern Izidor; Košnik Mitja; Čufer Tanja
    Predictive value of multidrug resistance proteins, topoisomerases II and ERCC1 in small cell lung cancer: a systematic review
    2011
  32. Gubenšek J; Adamlje T; Arnol M; Blanusa D; Ceglar Z; Cimerman-Steklasa S; Černe S; Čufer A; Drozg A; Ekart R; Guček A; Kandus A; Kapun S; Kralj-Lopert S; Kralj S; Likar C; Malovrh M; Močivnik M; Novljan G; Ponikvar R; Rukavina N; Saksida S; Buturović-Ponikvar J
    Hemodialysis patients refusing to be transplanted: data from the Slovenian renal replacement registry
    2010
  33. Knez Lea; Triller Nadja; Mrhar Aleš; Čufer Tanja
    Klinična farmacija - priložnost in prednost za bolnike na sistemskem zdravljenju raka: primer Enote za sistemsko terapijo raka na Kliniki Golnik
    2011
  34. Takač Iztok; Čufer Tanja; Gorišek Borut; Čas-Sikošek Nina; Bali Robert; Bosilj Damijana; Borštnar Simona; Lampelj Maja; Ravnik Maja; Kavalar Rajko; Fokter Nina; Arko Darja
    Vloga urokinaznega aktivatorja plazminogena (uPA) in njegovega inhibitorja (PAI-1) pri raku dojk
    [The role of the urokinase-type plasminogen activator (uPA) and its inhibitor (PAI-1) in breast cancer]
    2011
  35. Buturović-Ponikvar J; Adamlje T; Arnol M; Blanuša D; Ceglar Z; Cimerman-Steklasa S; Cerne S; Čufer A; Drozg A; Ekart R; Gubenšek J; Guček A; Kandus A; Kapun S; Kralj-Lopert S; Kralj S; Likar C; Malovrh M; Močivnik M; Novljan G; Ponikvar R
    Hemodialysis in Slovenia - data from the Slovenian renal replacement therapy registry
    2010
  36. Čufer Tanja
    Nujnih več študij o tem, pri katerih ženskah z rakom dojk Avastin res učinkuje
    2011
  37. Čufer Tanja
    Individualizirano sistemsko zdravljenje pljučnega raka: realnost ali utopija?
    2010
  38. Lunder Urška; Čufer Tanja
    Center odličnosti v celovitosti specifične onkološke in paliativne oskrbe
    2010
  39. Borštnar Simona; Grašič-Kuhar Cvetka; Matos Erika; Škof Erik; Čas-Sikošek Nina; Bosilj Damijana; Červek Jožica; Čufer Tanja
    Priporočila za zdravljenje bolnic s hormonsko odvisnim in HER 2-pozitivnim rakom dojk
    2010
  40. Čufer Tanja
    Problem je, da Slovenija v boju proti raku ne postavlja prioritet: intervju: prof. dr. Tanja Čufer, onkologinja in predsednica odbora IAC v združenju ASCO
    2010
  41. Čufer Tanja
    Individualizirano sistemsko zdravljenje raka pljuč
    2010
  42. Knez Lea; Jošt Maja; Toni Janez; Triller Nadja; Čufer Tanja
    Uvajanje novih farmacevtskih storitev ob prehodu na centralizirano pripravo protitumorskih zdravil
    [Implementing new clinical pharmacy services parallel to the introduction of centralized preparation of anti-cancer drugs]
    2011
  43. Čufer Tanja; Vrdoljak Eduard; Gaafar Rabab; Erensoy Inci; Pomberton Kristine
    Phase II, open-label, randomized study (SIGN) of single-agent gefitinib (Iressa) of docetaxel as second-line theapy in patients with advanced (stage IIIB of IV) non-small-cell lung cancer
    2010
  44. Čufer Tanja
    Barriers and challenges for academic cancer research
    2010
  45. Čufer Tanja
    Translation research on new molecular markers: an EORTC BCG experinece
    2010
  46. Turnšek Nina; Knez Lea; Čufer Tanja
    Neželeni učinki zdravljenja s tarčnimi zdravili
    2010
  47. Mohorčič Katja; Turnšek Nina; Sadikov Aleksander; Čufer Tanja
    Anemija pri bolnikih zdravljenih s kemoterapijo na Klniki Golnik v letu 2009
    2010
  48. Triller Nadja; Čufer Tanja
    Pljučni rak - novosti 2010
    2010
  49. Gubenšek J; Adamlje T; Arnol M; Blanusa D; Ceglar Z; Cimerman-Steklasa S; Černe S; Čufer A; Drozg A; Ekart R; Guček A; Kandus A; Kapun S; Kralj Lopert S; Kralj S; Likar C; Malovrh M; Močivnik M; Novljan G; Ponikvar R; Rukavina N; Rus R; Saksida S; Stevanovič Y; Buturović-Ponikvar J
    Hemodialysis patients after kidney graft failure: data from the Slovenian renal replacement registry
    2010
  50. Gubenšek J; Adamlje T; Arnol M; Blanusa D; Ceglar Z; Cimerman-Steklasa S; Černe S; Čufer A; Drozg A; Ekart R; Guček A; Kandus A; Močivnik M; Novljan G; Ponikvar R; Rukavina N; Rus R; Saksida S
    Hemodialysis patients refusing to be transplanted: data from the Slovenian renal replacement registry
    2010
  51. Buturović-Ponikvar J; Adamlje T; Arnol M; Blanuša D; Ceglar Z; Cimerman-Steklasa S; Černe S; Čufer A; Drozg A; Ekart R; Gubenšek J; Guček A; Kandus A; Kapun S; Kralj-Lopert S; Kralj S; Likar C; Malovrh M; Močivnik M; Novljan G; Ponikvar R; Rukavina N; Rus R; Saksida S; Stefanović Z
    Hemodialysis in Slovenia - data from the Slovenian renal replacement therapy registry
    2010
  52. Čufer Tanja
    Biološka zdravila za raka
    2010
  53. Čufer Tanja
    Karcinom pljuč: individualizirano sistemsko zdravljenje
    2010
  54. Buturović-Ponikvar Jadranka; Adamlje Tone; Blanuša Danica; Ceglar Zlata; Cimerman-Steklasa Sonja; Černe Senka; Čufer Andrej; Drozg Andrej; Ekart Robert; Guček Andrej; Kandus Aljoša; Kapun Sonja; Kralj-Lopert Simona; Kralj Stojan; Malovrh Marko; Močivnik Marjan; Novljan Gregor; Ponikvar Rafael; Rus Igor; Saksida Silvan; Vujkovac Bojan
    Slovenian renal replacement therapy registry: 2007 & 2008 annual report
    2010
  55. Ovčariček Tanja; Triller Nadja; Sadikov Aleksander; Čufer Tanja
    Prognostic value of C-reactive protein and other classical factors in patients with advanced non-small cell lung carcinoma treated in routine clinical practice
    [Napovedna vrednost C-reaktivnega proteina in drugih dejavnikov pri bolnikih z napredovalim nedrobnoceličnim karcinomom pljuč zdravljenih rutinsko v klinični praksi]
    2010
  56. Steger Guenther G; Čufer Tanja; Matos Erika
    Current standards in the treatment of metastatic breast cancer with focus on Lapatinib: #a #review by a Central European Consensus Panel
    2010
  57. Čufer Tanja
    Kaj je učinkovito zdravilo pri raku?: primer Avastin
    2010
  58. Rabaglio M; Sun Z; Price KN; Čufer T
    Bone fractures among postmenopausal patients with endocrine-responsive early breast cancer treated with 5 years of letrozole or tamoxifen in the BIG 1-98 trial
    2009
  59. Mouridsen Henning; Giobbie-Hurder Anita; Goldhirsch Aron; Čufer Tanja
    Letrozole therapy alone or in sequence with tamoxifen in women with breast cancer
    2009
  60. Borštnar Simona; Sadikov Aleksander; Možina Barbara; Čufer Tanja
    High levels of uPA and PAI-1 predict a good response to anthracyclines
    2010
  61. Čufer Tanja
    Biobanka: za boljšo oskrbo bolnikov z rakom
    2010
  62. Shepherd FA; Douillard J; Fukuoka M; Saijo N; Kim S; Čufer T; Sellers MV; Armour AA; Kim ES
    Comparison of gefitinib and docetaxel in patients with pretreated advanced non.slamm cell lungf cancer (NSCLC): meta-analysis from four clinical trials
    2009
  63. Čufer Tanja; Grašič-Kuhar Cvetka
    10 let specializacije iz internistične onkologije
    2010
  64. Grašič-Kuhar Cvetka; Ravnik Maja; Rotar-Pavlič Danica; Čufer Tanja
    Sledenje bolnikov z rakom
    2010
  65. Ravnik M; Snoj N; Sadikov A; Nussdorfer P; Čufer T
    Comparison of adjuvant! Online prediction with 10-year follow-up results according to the uPA and PAI-1 levels in Slovenian early breast cancer patients
    2010
  66. Humar Mojca; Čufer Tanja
    Priporočila za uporabo rastnih dejavnikov za eritrocite pri sistemsko zdravljenih bolnikih z rakom
    2009
  67. Čufer Tanja; Košnik Mitja
    Kako kritično brati strokovne in znanstvene članke? Obisk prof. Iana Tannocka
    2009
  68. Primic-Žakelj Maja; Zadnik Vesna; Žagar Tina; Zakotnik Branko; Anderluh Franc; Bešić Nikola; Černelč Peter; Čufer Tanja; Debeljak Andrej; Edhemović Ibrahim; Eržen Janez; Fras Albert-Peter; Gadžijev Eldar; Hočevar Marko; Jazbec Janez; Jezeršek Novaković Barbara; Kmetec Andrej; Majdič Elga; Mlakar Uroš; Modic Mojca; Oblak Irena; Ocvirk Janja; Omejc Mirko; Repše Stanislav; Sedmak Boris; Smrdel Uroš; Sok Mihael; Strojan Primož; Škrbinc Breda; Šmid Alojz; Uršič-Vrščaj Marjetka; Velenik Vaneja; Zver Samo; Zwitter Matjaž; Žgajnar Janez; Žumer-Pregelj Mirjana; Shrestha Olga
    Preživetje bolnikov z rakom, zbolelih v letih 1991-2005 v Sloveniji
    2009
  69. Buturović-Ponikvar Jadranka; Adamlje Tone; Blanuša Danica; Ceglar Zlata; Cimerman-Steklasa Sonja; Černe Senka; Čufer Andrej; Drozg Andrej; Ekart Robert; Guček Andrej; Kandus Aljoša; Kapun Sonja; Kralj-Lopert Simona; Kralj Stojan; Malovrh Marko; Močivnik Marjan; Novljan Gregor; Ponikvar Rafael; Rukavina Nikola; Rus Igor; Saksida Silvana; Vujkovac Bojan
    Slovenian renal replacement therapy registry: excerpts from the 2006 annual report
    2009
  70. Lekič M; Triller N; Knez L; Sadikov A; Čufer T
    Analiza bolnikov z drobnoceličnim rakom pljuč in možganskimi zasevki v naši klinični praksi
    2009
  71. Vrzel M; Toni J; Morgan T; Košnik M; Čufer T; Mrhar A
    Vrednotenje protibolečinske terapije pri bolnikih z rakom v Bolnišnici Golnik
    2009
  72. Čufer Tanja
    Neželeni učinki sistemskega zdravljenja raka in njihovo obvladovanje
    2009
  73. Vrzel M; Toni J; Morgan T; Košnik M; Čufer T; Mrhar A
    Prescription of laxatives in cancer patients treated with opioids
    2009
  74. Ribnikar Domen; Fink Špela; Frković-Grazio Snježana; Sadikov Aleksander; Lešničar Hotimir; Čufer Tanja
    Clinical course of HER-2 positive breast cancer patients
    2009
  75. Ravnik M; Sadikov A; Snoj N; Nussdorfer P; Ravnik J; Čufer T
    Comparison of adjuvant predicted and observed overall survival in subgroups of estrogen receptor positive breast cancer patients
    2009
  76. Ovčariček Tanja; Triller Nadja; Sadikov Aleksander; Čufer Tanja
    Prognostic value of C-reactive protein and other factors in patients with advanced non-small cell lung cancer
    2009
  77. Unk M; Triller N; Knez L; Sadikov A; Zakotnik B; Čufer T
    Outcome of patients with limited-stage small cell lung cancer (LSCLC) in a routine clinical setting
    2009
  78. Lekič M; Triller N; Knez L; Sadikov A; Čufer T
    Outcome of small cell lung cancer (SCLC) patients with brain metastases in a routine clinical setting
    2009
  79. Buturović-Ponikvar J; Adamlje T; Blanuša D; Ceglar Z; Cimerman-Steklasa S; Černe S; Čufer A; Drozg A; Ekart R; Guček A; Kandus A; Kapun S; Kralj-Lopert S; Kralj S; Malovrh M; Močivnik M; Novljan G; Ponikvar R; Rukavina N; Rus I; Saksida S; Vujkovac B
    Vascular access for hemodialysis patients in Slovenia-data from the Slovenian renal replacement therapy registry 2006
    2009
  80. Buturović-Ponikvar J; Adamlje T; Blanuša D; Ceglar Z; Cimerman-Steklasa S; Černe S; Čufer A; Drozg A; Ekart R; Guček A; Kandus A; Kapun S; Kralj-Lopert S; Kralj S; Malovrh M; Močivnik M; Novljan G; Ponikvar R; Rukavina N; Rus I; Saksida S; Vujkovac B
    Hemodialysis in Slovenia: data from the Slovenian renal replacement therapy registry 2006
    2009
  81. Buturović-Ponikvar Jadranka; Adamlje Tone; Blanuša Danica; Ceglar Zlata; Simerman Sonja; Černe Senka; Čufer Andrej; Drozg Andrej; Ekart Robert; Guček Andrej; Kandus Aljoša; Kapun Sonja; Kralj-Lopert Simona; Kralj Stojan; Malovrh Marko; Močivnik Marjan; Novljan Gregor; Ponikvar Rafael; Rukavina Nikola; Rus Igor; Saksida Silvan; Vujkovac Bojan
    Nadomestno zdravljenje ledvične odpovedi v Sloveniji - izsledki iz letnega poročila 2006
    2009
  82. Čufer Tanja
    Letno srečanje skupin EORTC: (Evropske organizacije za raziskave in zdravljenje raka)
    2009
  83. Gruber G; Cole BF; Castiglione-Gertsch M; Holmberg SB; Lindtner J; Golouh R; Collins J; Crivellari D; Thurlimann B; Simoncini E; Fey MF; Gelber RD; Coates AS; Price KN; Goldhirsch A; Viale G; Gusterson BA; Eržen D; Čufer T; Majdič E; Štabuc B; Lamovec J; Jančar J; Vrhovec I; Kramberger M; Novak J; Naglas M; Senčar M; Červek J; Šebek S; Cerar O; Plesničar A; Zakotnik B
    Extracapsular tumor spread and the risk of local, axillary and supraclavicular recurrence in node-positive, premenopausal patients with breast cancer
    2008
  84. Harbeck Nadia; Nimmrich Inko; Hartmann Arndt; Ross Jeffrey S; Čufer Tanja; Grutzmann Robert; Kristiansen Glen; Paradiso Angelo; Hartmann Oliver; Margossian Astrid
    Multicenter study using paraffin-embedded tumor tissue testing PITX2 DNA methylation as a marker for outcome prediction in tamoxifen-treated, node-negative breast cancer patients
    2008
  85. Golouh R; Čufer T; Sadikov A; Nussdorfer P; Usher PA; Brunner N; Schmitt M; Lesche R; Maier S; Timmermans M; Foekens JA; Martens JW
    The prognostic value of Stathmin-1, S100A2, and SYK proteins in ER-positive primary breast cancer patients treated with adjuvant tamoxifen monotherapy: an immunohistochemical study
    2008
  86. Thurlimann Beat; Price Karen N; Gelber Richard D; Holmberg Stig B; Crivellari Diana; Colleoni Marco; Collins John; Forbes John F; Castiglione-Gertsch Monica; Lindtner J; Eržen D; Čufer T; Červek J; Cerar O; Zakotnik B; Majdič E; Golouh R; Lamovec J; Jančar J; Vrhovec I; Kramberger M
    Is chemotherapy necessary for premenopausal women with lower-risk node-positive, endocrine responsive breast cancer? 10-year update of International Breast Cancer Study Group Trial 11-93
    2009
  87. Paridaens Robert J; Dirix LucY; Beex Louk V; Nooij Marianne; Cameron David A; Čufer Tanja; Piccart Martine J; Bogaerts Jan; Therasse Patrick
    Phase III study comparing exemestane with tamoxifen as first-line hormonal treatment of metastatic breast cancer in postmenopausal women: the European Organisation for Research and Treatment of Cancer Breast Cancer Cooperative Group
    2008
  88. Zhang Yi; Sieuwerts Anieta M; McGreevy Michelle; Casey Graham; Čufer Tanja; Paradiso Angelo; Harbeck Nadia; Span Paul N; Hicks David G; Golouh Rastko
    The 76-gene signature defines high-risk patients that benefit from adjuvant tamoxifen therapy
    2009
  89. Pagani O; Gelber S; Simoncini E; Castiglione-Gertsch M; Price KN; Gelber RD; Holmberg SB; Crivellari D; Lindtner J; Čufer T
    Is adjuvant chemotherapy of benefit for postmenopausal women who receive endocrine treatment for highly endocrine-responsive, node-positive breast cancer? International Breast Cancer Study Group Trials VII and 12-93
    2009
  90. Viale Giuseppe; Giobbie-Hurder Anita; Regan Meredith M; Coates Alan S; Mastropasqua Mauro G; Dell'Orto Patrizia; Maiorano Eugenio; MacGrogan Gaetan; Braye Stephen G; Čufer Tanja
    Prognostic and predictive value of centrally reviewed Ki-67 labeling index in postmenopausal women with endocrine-responsive breast cancer: results from Breast International Group Trial 1-98 comparing adjuvant tamoxifen with letrozole
    2008
  91. Ortmann Olaf; Čufer Tanja; Dixon J Michael; Maass Nicolai; Marchetti Paolo; Pagani Olivia; Pronzato Paolo; Semiglazov Vladimir; Spano Jean-Philippe; Vrdoljak Eduard; Wildiers Hans
    Adjuvant endocrine therapy for perimenopausal women with early breast cancer
    2009
  92. von Minckwitz Gunter; du Bois Andreas; Schmidt Marcus; Maass Nicolai; Čufer Tanja; de Jongh Felix E; Maartense Eduard; Zielinski Christoph; Kaufmann Manfred; Bauer Wolfgang
    Trastuzumab beyond progression in human epidermal growth factor receptor 2-positive advanced breast cancer: a german breast group 26/breast international group 03-05 study
    2009
  93. Aebersold R; Auffray C; Baney E; Barillot E; Brazma A; Brett C; Čufer T; Hace N; Seljak M; Zupan Blaž
    Report on EU-USA workshop: how systems biology can advance cancer research (27 October 2008)
    2009
  94. Giobbie-Hurder A; Price KN; Gelber RD; Čufer T
    Design, conduct, and analyses of Breast International Group (BIG) 1-98: a randomized, double-blind, phase-III study comparing letrozole and tamoxifen as adjuvant endocrine therapy for postmenopausal women with receptor-positive, early breast cancer
    2009
  95. Cardoso F; Bedard PL; Winer EP; Pagani O; Senkus-Konefka E; Fallowfield LJ; Kyriakides S; Costa A; Čufer T; Albain KS
    International Guidelines for Management of Metastatic Breast Cancer: Combination vs Sequential Single-Agent Chemotherapy
    2009
  96. Snoj N; Čufer T
    Two faces of screen detected cancers
    2009
  97. Ravnik M; Sadikov A; Snoj N; Nussdorfer P; Čufer T
    Validation of Adjuvant online on Slovenian collective of hormone receptor (HR) positive early breast cancer patients
    2009
  98. Gazić Barbara; Pižem Jože; Bračko Matej; Čufer Tanja; Borštnar Simona; Pohar-Marinšek Živa; Us-Krašovec Marija
    S-phase fraction determined on fine needle aspirates is an independent prognostic factor in breast cancer: a multivariate study of 770 patients
    2008
  99. Snoj Nataša; Paridaens Robert; Čufer Tanja
    Current controversies in extended adjuvant endocrine therapy for early breast cancer
    2008
  100. Unk M; Triller N; Knez L; Sadikov A; Zakotnik B; Čufer T
    Outcome of patients with limited-stage small cell lung cancer (LSCLC) in a routine clinical setting
    2009

   1 82 182 282 382 482  


New search      Comments      Top of page Institute for Biostatistics and Medical Informatics